| 1 |
DADJO-GUEWA,张延龄,金忱,等.组织多肽特异性抗原.国外医学（外科学分册）,2004,31(3):152-155.
|
| 2 |
D'Alessandro R,Roselli M,Ferroni P,et al.Serum tissue polypeptide specific antigen(TPS):a complementary tumor marker to CA15-3 in the management of breast cancer.Breast Cancer Res Treat,2001,68(1):9-19.
|
| 3 |
Eskelinen M, Hippelainen M, Salmela E, et al. A prospective study of tissue polypeptide specific antigen (TPS) in breast cancer diagnosis. Anticancer Res,1992,12(68):2033-2036.
|
| 4 |
Kopczynski Z, Wozniak A. The diagnostic value of determination of tissue polypeptide specific antigen (TPS) in serum of women with breast cancer.Ginekol Pol,1997,68(2):78-82.
|
| 5 |
Sliwowska I, Kopczynski Z, Grodecka S. Diagnostic value of measuring serum CA15-3, TPA and TPS in women with breast cancer. Postepy Hig Med Dosw(Online),2006,60:295-299.
|
| 6 |
Coussens L, Yang F, Liao YC. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science,1985,230(4730):1132-1139.
|
| 7 |
华彬，韦军民.乳癌HER-2 基因研究的进展与现状.中国医刊,2006,41(1):46-47.
|
| 8 |
Disis ML,Schiffman K.Cancer vaccines targeting the HER2／neu oncogemc protein.Semin Oncol,2001,28(6 Suppl 18):12-20.
|
| 9 |
Brandt-Rauf PW, Luo JC, Carney WP, et a1. Detection of increased amounts of the extracellular domain of the c-erbB-2 oncoprotein in serum during pulmonary carcinogenesis in humans.Int J Cancer,1994,56(3):383-386.
|
| 10 |
金海甲,曾常茜,王振明,等.BA-ELISA 法检测乳腺癌患者p185.中国医师杂志,2004,6(6):835-836.
|
| 11 |
Tsutsui S,Ohno S,Murakami S,et al.Prognostic value of c-erbB2 expression in breast cancer.J Surg Oncol,2002,79(4):216-223.
|
| 12 |
Tokino T,Nakamura Y.The role of p53-target genes in human cancer.Crit Rev Oncol Hematol,2000,33(1):1-6.
|
| 13 |
赵启军,张瑞明.P53 基因家族的研究进展.内蒙古医学杂志,2006,38(3):270-272.
|
| 14 |
Sangrajrang S, Arpomwirat W, Cheirsilpa A, et al. Serum p53 antibodies in correlation to other biological parameters of breast cancer. Cancer Detect Prev,2003,27(3):182-186.
|
| 15 |
范火亮.乳腺癌p53 蛋白表达及其血清抗体检测分析.中国热带医学,2006,6(5):768-769.
|
| 16 |
Muller M, Meyer M, Schiling T, et al. Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor makers. Int J Oncol,2006,29(4):973-980.
|
| 17 |
Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta, 1996, 1275(3) :161-203.
|
| 18 |
刘璐,刘瑶,严玉仙.铁蛋白.国外医学(医学地理分册),2005,26(4):171-172.
|
| 19 |
Ulbrich EJ, Lebrecht A, Schneider I, et al. Serum parameters of iron metabolism in patients with breast cancer. Anticancer Res, 2003, 23(60):5107-5109.
|
| 20 |
Kokocinska D, Widala E, Donocik J, et al. The value of evaluating tumor markers: CA 15-3 and ferritin in blood serum of patients grouped as ＂high risk＂for breast cancer.Przegl Lek,1999,56(10):664-667.
|
| 21 |
洪锡田,王景萍,张瑞丽.血清CA153、CA125、CEA、SF 检测在乳腺癌诊断中的价值.中国民康医学,2007,19(1):23-24.
|